Cargando…

Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801

Detalles Bibliográficos
Autores principales: Yamaguchi, Fuminori, Hirata, Yuko, Akram, Hossain, Kamitori, Kazuyo, Dong, Youyi, Sui, Li, Tokuda, Masaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204986/
https://www.ncbi.nlm.nih.gov/pubmed/35715788
http://dx.doi.org/10.1186/s12885-022-09764-1
_version_ 1784729035060805632
author Yamaguchi, Fuminori
Hirata, Yuko
Akram, Hossain
Kamitori, Kazuyo
Dong, Youyi
Sui, Li
Tokuda, Masaaki
author_facet Yamaguchi, Fuminori
Hirata, Yuko
Akram, Hossain
Kamitori, Kazuyo
Dong, Youyi
Sui, Li
Tokuda, Masaaki
author_sort Yamaguchi, Fuminori
collection PubMed
description
format Online
Article
Text
id pubmed-9204986
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92049862022-06-18 Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801 Yamaguchi, Fuminori Hirata, Yuko Akram, Hossain Kamitori, Kazuyo Dong, Youyi Sui, Li Tokuda, Masaaki BMC Cancer Editorial Expression of Concern BioMed Central 2022-06-17 /pmc/articles/PMC9204986/ /pubmed/35715788 http://dx.doi.org/10.1186/s12885-022-09764-1 Text en © BioMed Central 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Editorial Expression of Concern
Yamaguchi, Fuminori
Hirata, Yuko
Akram, Hossain
Kamitori, Kazuyo
Dong, Youyi
Sui, Li
Tokuda, Masaaki
Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801
title Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801
title_full Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801
title_fullStr Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801
title_full_unstemmed Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801
title_short Editorial Expression of Concern: FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801
title_sort editorial expression of concern: foxo/txnip pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist mk-801
topic Editorial Expression of Concern
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204986/
https://www.ncbi.nlm.nih.gov/pubmed/35715788
http://dx.doi.org/10.1186/s12885-022-09764-1
work_keys_str_mv AT yamaguchifuminori editorialexpressionofconcernfoxotxnippathwayisinvolvedinthesuppressionofhepatocellularcarcinomagrowthbyglutamateantagonistmk801
AT hiratayuko editorialexpressionofconcernfoxotxnippathwayisinvolvedinthesuppressionofhepatocellularcarcinomagrowthbyglutamateantagonistmk801
AT akramhossain editorialexpressionofconcernfoxotxnippathwayisinvolvedinthesuppressionofhepatocellularcarcinomagrowthbyglutamateantagonistmk801
AT kamitorikazuyo editorialexpressionofconcernfoxotxnippathwayisinvolvedinthesuppressionofhepatocellularcarcinomagrowthbyglutamateantagonistmk801
AT dongyouyi editorialexpressionofconcernfoxotxnippathwayisinvolvedinthesuppressionofhepatocellularcarcinomagrowthbyglutamateantagonistmk801
AT suili editorialexpressionofconcernfoxotxnippathwayisinvolvedinthesuppressionofhepatocellularcarcinomagrowthbyglutamateantagonistmk801
AT tokudamasaaki editorialexpressionofconcernfoxotxnippathwayisinvolvedinthesuppressionofhepatocellularcarcinomagrowthbyglutamateantagonistmk801